C0282563||macrolides
C0544570||antibacterial
C0021747||type I
C0021747||III IFN
C0243095||augmenting activity
C0458827||airway
C0014609||epithelium
C0349790||Exacerbations of asthma
C0740304||COPD
C0035473||rhinoviruses
C1512758||inflammatory pathways
C1155328||antiviral immunity
C0282563||Macrolides
C0052796||azithromycin
C0012634||diseases
C0021368||inflammation
C1155328||antiviral immunity
C0947630||study
C0282563||macrolides
C1321382||antiviral activity
C0035473||rhinovirus
C0243095||anti-inflammatory activity
C0018154||Gram-positive
C0018150||Gram-negative bacteria
C1711178||bronchial epithelial cells
C0282563||macrolides
C0035473||rhinovirus
C0042774||replication
C0332128||examined
C0282563||macrolides
C0332128||examined
C0028923||oleandomycin
C0028923||Mac5
C0052796||azithromycin
C0035473||rhinovirus
C1334081||type I IFNβ
C1334085||type III IFNλ1
C1334085||type III IFNλ2/3
C0035696||mRNA
C0021747||IFN
C0017337||genes
C1539703||viperin
C1417510||MxA
C1334122||IL-6
C1366571||IL-8
C0035696||mRNA
C0028923||Mac5
C0035473||rhinovirus
C0042774||replication
C1321382||antiviral activity
C0028923||Mac5
C0544570||antibacterial activity
C0018154||Gram-positive
C0038410||Streptococcus pneumoniae
C0544570||antibacterial properties
C0052796||azithromycin
C0018150||Gram-negative
C0014834||Escherichia coli
C0033809||Pseudomonas aeruginosa
C0018483||Haemophilus influenzae
C0028923||Mac5
C1321382||antiviral
C0544570||antibacterial activities
C0282563||macrolides
C1321382||antiviral properties
C0282563||macrolides
C0544570||antibacterial
C1321382||antiviral activity